Worth Venture Partners, LLC Prothena Corp Public LTD CO Put Options Transaction History

Worth Venture Partners, LLC

  • $34.6 Million
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2018

Aug 13, 2018
SELL
$10.99 - $44.21 $151,662 - $610,098
-13,800 Closed
0 $0
Q1 2018

May 25, 2018
SELL
$27.95 - $45.04 $38.2 Million - $61.5 Million
-1,366,200 Reduced 99.0%
13,800 $187,000
Q1 2018

May 11, 2018
BUY
$27.95 - $45.04 $38.5 Million - $62 Million
1,377,100 Added 47486.21%
1,380,000 $187,000
Q4 2017

Feb 14, 2018
BUY
$35.44 - $63.76 $102,776 - $184,904
2,900
2,900 $35,000

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $678M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email